Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer

Por Song, Lanxi, Smith, Matthew A., Doshi, Parul, Sasser, Kate, Fulp, William, Altiok, Soner, Haura, Eric B.
Publicado em 2014

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers

Por Moisan, Francois, Francisco, Edgar B., Brozovic, Anamaria, Duran, George E., Wang, Yan C., Chaturvedi, Shalini, Seetharam, Shobha, Snyder, Linda A., Doshi, Parul, Sikic, Branimir I.
Publicado no Mol Oncol (2014)

The human CD38 monoclonal antibody daratumumab shows anti-tumor activity and hampers leukemia-microenvironment interactions in chronic lymphocytic leukemia

Por Matas-Céspedes, Alba, Vidal-Crespo, Anna, Rodriguez, Vanina, Villamor, Neus, Delgado, Julio, Giné, Eva, Roca-Ho, Heleia, Menéndez, Pablo, Campo, Elías, López-Guillermo, Armando, Colomer, Dolors, Roué, Gaël, Wiestner, Adrian, Parren, Paul W.H.I., Doshi, Parul, van Bueren, Jeroen Lammerts, Pérez-Galán, Patricia
Publicado no Clin Cancer Res (2016)

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

Por de Haart, Sanne J., Holthof, Lisa, Noort, Willy A., Minnema, Monique C., Emmelot, Maarten E., Aarts-Riemens, Tineke, Doshi, Parul, Sasser, Kate, Yuan, Huipin, de Bruijn, Joost, Martens, Anton C.M., van de Donk, Niels W.C.J, Lokhorst, Henk M., Groen, Richard W.J., Mutis, Tuna
Publicado no Haematologica (2016)